Effects of the novel glycopeptide opioid agonist MMP-2200 in preclinical models of Parkinson's disease

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 01, 2011
Source ID
10.1016/j.brainres.2011.07.038

Entities

People

  • Frank Porreca
  • Lajos Szabò
  • Leslie A. Zuniga
  • Robin Polt
  • Scott J. Sherman
  • Torsten Falk
  • Xu Yue

Organizations

  • National Institutes of Health
  • National Science Foundation
  • Office of Naval Research